Comparison of Endocrine Profile and In Vitro Fertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries

Overview

Journal Int J Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2012 Apr 21

PMID 22518124

Citations 6

Authors

Yi-Ping Zhong

Ying Ying

Hai-Tao Wu

Can-Quan Zhou

Yan-Wen Xu

Qiong Wang

Jie Li

Xiao-Ting Shen

Jin Li

Affiliations

Soon will be listed here.

Abstract

Aim. To compare the basic endocrine profile and outcomes of in vitro fertilization (IVF) in women with polycystic ovary syndrome (PCOS), ovulatory polycystic ovaries (PCO), or normal ovaries (NO). Methods. The basic clinical features and in vitro fertilization and embryo transfer outcome in patients receiving IVF or intracytoplasmic sperm injection (ICSI) were retrospectively analyzed. Results. The body mass index, basal luteinizing hormone, and testosterone levels were significantly lower in patients with ovulatory PCO compared to those in patients with PCOS. The PCOS patients exhibited the shortest duration of ovarian stimulation and lowest dose of gonadotropin, followed by the ovulatory PCO and NO patients. The ovulatory PCO and PCOS patients showed similar levels of E2 on the human chorionic gonadotropin treatment day and numbers of oocytes, which were both significantly higher than those of the NO patients. The fertilization rate of the PCOS patients was significantly lower than the other two groups. Compared to NO patients, the cleavage rate was lower in both PCOS and ovulatory PCO patients, however, the number of available embryos was significantly more in these two groups. The incidence of the moderate to severe ovarian hyperstimulation syndrome (OHSS) was markedly higher in the PCOS and ovulatory PCO patients. Conclusion. Ovulatory PCO patients do not express similar endocrine abnormalities as PCOS patients. Although the fertilization rate and cleavage rate were relatively low in PCOS patients, ultimately, all the three groups showed similar transferred embryo numbers, clinical pregnancy rates, and implantation rates. Since the incidence of OHSS was much higher in the PCOS and ovulatory PCO patients, we should take more care of these patients and try to prevent severe OHSS.

Citing Articles

In Vitro Fertilization Cycle Outcomes for a Patient Undergoing Oocyte Retrieval following Ovarian Torsion.

Mortimer R, Gordon C, Srouji S CRSLS. 2023; 10(1).

PMID: 37006379 PMC: 10065751. DOI: 10.4293/CRSLS.2022.00092.

Female Reproductive Aging and Oxidative Stress: Mesenchymal Stem Cell Conditioned Medium as a Promising Antioxidant.

Ra K, Park S, Lee B Int J Mol Sci. 2023; 24(5).

PMID: 36902477 PMC: 10002910. DOI: 10.3390/ijms24055053.

Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence?.

Medenica S, Spoltore M, Ormazabal P, Marina L, Sojat A, Faggiano A Clin Endocrinol (Oxf). 2022; 98(2):141-152.

PMID: 35644933 PMC: 10084349. DOI: 10.1111/cen.14785.

Effects of propylene glycol or elevated luteinizing hormone during follicle development on ovulation, fertilization, and early embryo development.

Hackbart K, Bender R, Carvalho P, Vieira L, Dresch A, Guenther J Biol Reprod. 2017; 97(4):550-563.

PMID: 28575154 PMC: 6248555. DOI: 10.1093/biolre/iox050.

Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation?.

Vaz G, Evangelista A, Sartorio C, Cardoso M, Erthal M, Gallo P Biomed Res Int. 2016; 2016:5701609.

PMID: 27190994 PMC: 4844867. DOI: 10.1155/2016/5701609.

References

Doyle L, Walker C, Donadeu F . VEGF modulates the effects of gonadotropins in granulosa cells. Domest Anim Endocrinol. 2009; 38(3):127-37. DOI: 10.1016/j.domaniend.2009.08.008. View

Johnstone E, Rosen M, Neril R, Trevithick D, Sternfeld B, Murphy R . The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab. 2010; 95(11):4965-72. PMC: 2968725. DOI: 10.1210/jc.2010-0202. View

Tehraninejad E, Nasiri R, Rashidi B, Haghollahi F, Ataie M . Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients. Arch Gynecol Obstet. 2010; 282(3):319-25. DOI: 10.1007/s00404-010-1429-x. View

Balen A, Conway G, Kaltsas G, Techatrasak K, Manning P, West C . Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995; 10(8):2107-11. DOI: 10.1093/oxfordjournals.humrep.a136243. View

Tang T, Glanville J, Orsi N, Barth J, Balen A . The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006; 21(6):1416-25. DOI: 10.1093/humrep/del025. View

Agrawal R, Conway G, Sladkevicius P, Tan S, Engmann L, Payne N . Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril. 1998; 70(4):651-8. DOI: 10.1016/s0015-0282(98)00249-0. View

Child T, Abdul-Jalil A, Gulekli B, Tan S . In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril. 2001; 76(5):936-42. DOI: 10.1016/s0015-0282(01)02853-9. View

Wang J, Davies M, Norman R . Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod. 2001; 16(12):2606-9. DOI: 10.1093/humrep/16.12.2606. View

Genazzani A, Petraglia F, Battaglia C, Gamba O, Volpe A, Genazzani A . A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. Fertil Steril. 1997; 67(3):463-8. DOI: 10.1016/s0015-0282(97)80070-2. View

10.

Esinler I, Bayar U, Bozdag G, Yarali H . Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril. 2005; 84(4):932-7. DOI: 10.1016/j.fertnstert.2005.04.028. View

11.

Adams J, Taylor A, Crowley Jr W, Hall J . Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab. 2004; 89(9):4343-50. DOI: 10.1210/jc.2003-031600. View

12.

Jarvela I, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G . Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography. Fertil Steril. 2004; 82(5):1358-63. DOI: 10.1016/j.fertnstert.2004.04.048. View

13.

Balen A, Tan S, MacDougall J, Jacobs H . Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod. 1993; 8(6):959-64. DOI: 10.1093/oxfordjournals.humrep.a138174. View

14.

Swanton A, Lighten A, Granne I, McVeigh E, Lavery S, Trew G . Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial. Hum Reprod. 2011; 26(8):2178-84. DOI: 10.1093/humrep/der120. View

15.

Sahu B, Ozturk O, Ranierri M, Serhal P . Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet. 2007; 277(3):239-44. DOI: 10.1007/s00404-007-0462-x. View

16.

Sayin N, Gucer F, Balkanli-Kaplan P, Yuce M, Yardim T . Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome. Gynecol Endocrinol. 2004; 17(5):387-96. DOI: 10.1080/09513590312331290278. View

17.

Kousta E, White D, Cela E, McCarthy M, Franks S . The prevalence of polycystic ovaries in women with infertility. Hum Reprod. 1999; 14(11):2720-3. DOI: 10.1093/humrep/14.11.2720. View

18.

Orvieto R, Meltcer S, Homburg R, Nahum R, Rabinson J, Ashkenazi J . What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?. Fertil Steril. 2008; 91(4 Suppl):1466-8. DOI: 10.1016/j.fertnstert.2008.07.1711. View

19.

Esmailzadeh S, Faramarzi M, Jorsarai G . Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology. Eur J Obstet Gynecol Reprod Biol. 2005; 121(1):67-70. DOI: 10.1016/j.ejogrb.2004.12.002. View

20.

Coffler M, Patel K, Dahan M, Malcom P, Kawashima T, Deutsch R . Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88(4):1742-7. DOI: 10.1210/jc.2002-021280. View